- Home
- RLAY vs QS Comparison
RLAY vs QS Comparison
Compare RLAY & QS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLAY | QS |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.6B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | RLAY | QS |
|---|---|---|
| Price | $19.76 | $5.72 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 6 |
| Target Price | ★ $19.50 | $9.38 |
| AVG Volume (30 Days) | 2.1M | ★ 19.9M |
| Earning Date | 05-05-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.78 | 19.15 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,355,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $324.03 | $1,827.70 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 53.44 | N/A |
| 52 Week Low | $3.44 | $4.77 |
| 52 Week High | $21.27 | $19.07 |
Technical Indicators
Market Signals| Indicator | RLAY | QS |
|---|---|---|
| Relative Strength Index (RSI) | 54.17 | 45.31 |
| Support Level | $18.02 | $4.77 |
| Resistance Level | $20.59 | $7.21 |
| Average True Range (ATR) | 0.93 | 0.28 |
| MACD | -0.09 | 0.04 |
| Stochastic Oscillator | 48.31 | 30.87 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
About QS QuantumScape Corporation
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles and other applications. The company's solid-state lithium-metal battery technology is designed to offer greater energy density, faster charging, and enhanced safety. Its battery cells have none of the host materials used in conventional nodes. The company operates in one operating segment only.